| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | - | - | - | 0 | 20.874 | 114.675 | 139.874 |
| Total Income - EUR | - | - | - | - | - | - | 0 | 20.874 | 114.675 | 140.026 |
| Total Expenses - EUR | - | - | - | - | - | - | 120 | 12.932 | 62.176 | 80.628 |
| Gross Profit/Loss - EUR | - | - | - | - | - | - | -120 | 7.942 | 52.499 | 59.398 |
| Net Profit/Loss - EUR | - | - | - | - | - | - | -120 | 7.847 | 51.409 | 55.407 |
| Employees | - | - | - | - | - | - | 0 | 1 | 1 | 2 |
Check the financial reports for the company - Clinicile Pink S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | - | - | - | 94 | 20 | 445 | 518 |
| Current Assets | - | - | - | - | - | - | 53 | 8.138 | 60.730 | 56.651 |
| Inventories | - | - | - | - | - | - | 0 | 0 | 101 | 0 |
| Receivables | - | - | - | - | - | - | 0 | 0 | 56.787 | 27.029 |
| Cash | - | - | - | - | - | - | 53 | 8.138 | 3.842 | 29.622 |
| Shareholders Funds | - | - | - | - | - | - | -79 | 7.767 | 51.458 | 55.455 |
| Social Capital | - | - | - | - | - | - | 40 | 41 | 40 | 40 |
| Debts | - | - | - | - | - | - | 226 | 391 | 10.638 | 2.660 |
| Income in Advance | - | - | - | - | - | - | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8623 - 8623" | |||||||||
| CAEN Financial Year |
8623
|
|||||||||
Comments - Clinicile Pink S.r.l.